- Kenvue's stock gains as Third Point Capital reveals a new stake, signaling increased investor interest.
- Analyst consensus sets a potential upside for Kenvue with varied price targets.
- Current brokerage recommendations suggest holding Kenvue shares.
Kenvue (KVUE, Financial), recently spun off from the reputable Johnson & Johnson, has captured investor attention as Dan Loeb’s Third Point Capital disclosed its stake in the consumer-focused company. While the particulars of this investment remain undisclosed, this move signifies the third concerted activist effort directed at Kenvue, well-known for its Band-Aid brand.
Wall Street Analysts Forecast
The consensus among 14 seasoned analysts forecasts an average target price of $24.29 for Kenvue Inc (KVUE, Financial), with projections ranging from a high of $29.00 to a low of $22.00. These figures suggest a potential upside of 5.54% from the current trading price of $23.02. For those seeking further insights, additional detailed projections can be accessed on the Kenvue Inc (KVUE) Forecast page.
Adding to the investment outlook, 19 brokerage firms have provided a collective recommendation, placing Kenvue Inc's (KVUE, Financial) average recommendation at 2.6. This places the stock in the "Hold" category on a scale from 1 to 5, where 1 indicates a "Strong Buy" and 5 suggests a "Sell".
